Pacira BioSciences Files 8-K
Ticker: PCRX · Form: 8-K · Filed: Aug 9, 2024 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Aug 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
Related Tickers: PCRX
TL;DR
PCRX filed an 8-K, check for updates.
AI Summary
Pacira BioSciences, Inc. (PCRX) filed an 8-K on August 9, 2024, reporting other events and financial statements. The company, formerly known as Pacira Pharmaceuticals, Inc., is incorporated in Delaware and headquartered in Tampa, Florida.
Why It Matters
This filing indicates Pacira BioSciences is making official disclosures to the SEC, which could include significant business updates or financial reporting relevant to investors.
Risk Assessment
Risk Level: low — This is a routine SEC filing for a public company, not indicating immediate or significant risk.
Key Numbers
- 001-35060 — SEC File Number (Identifies the company's filing with the SEC.)
- 51-0619477 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- Pacira Pharmaceuticals, Inc. (company) — Former company name
- Blue Acquisition Corp (company) — Former company name
- August 9, 2024 (date) — Date of report
- Tampa, Florida (location) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Pacira BioSciences in this 8-K filing?
The provided text does not detail the specific 'Other Events' beyond listing it as an item information category.
When was Pacira BioSciences, Inc. incorporated?
Pacira BioSciences, Inc. was incorporated in Delaware.
What is the principal executive office address for Pacira BioSciences, Inc.?
The principal executive offices are located at 5401 West Kennedy Boulevard, Suite 890, Tampa, Florida 33609.
What was Pacira BioSciences, Inc. previously named?
The company was formerly known as Pacira Pharmaceuticals, Inc., and prior to that, PACIRA INC and Blue Acquisition Corp.
What is the SIC code for Pacira BioSciences, Inc.?
The Standard Industrial Classification (SIC) code is 2834, for Pharmaceutical Preparations.
Filing Stats: 442 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-08-09 15:23:04
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share PCRX Nasdaq Global Select Mar
Filing Documents
- pcrx-20240809.htm (8-K) — 24KB
- pcrx-p4pressreleaseexhibit.htm (EX-99.1) — 13KB
- pacirabiosciencesa01a.jpg (GRAPHIC) — 27KB
- 0001396814-24-000103.txt ( ) — 200KB
- pcrx-20240809.xsd (EX-101.SCH) — 2KB
- pcrx-20240809_lab.xml (EX-101.LAB) — 21KB
- pcrx-20240809_pre.xml (EX-101.PRE) — 12KB
- pcrx-20240809_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On August 9, 2024, Pacira BioSciences, Inc. (the "Company") issued a press release with respect to the U.S. District Court for the District of New Jersey's ruling in the Company's patent infringement suit against eVenus Pharmaceutical Laboratories, Inc. and its parent company for infringement of EXPAREL (bupivacaine liposome injectable suspension), U.S. Patent No. 11,033,495. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release dated August 9 2024. 104 Cover Page Interactive Data File (Formatted as Inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PACIRA BIOSCIENCES, INC. (REGISTRANT) Dated: August 9, 2024 By: /s/ KRISTEN WILLIAMS Kristen Williams Chief Administrative Officer and Secretary